Predictors of Disease Worsening Defined by Progression of Organ Damage in Diffuse Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2019-215145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Classification, Categorization and Essential Items for Digital Ulcer Evaluation in Systemic Sclerosis: A DeSScipher/European Scleroderma Trials and Research Group (EUSTAR) Survey

Arthritis Research & Therapy
2019English

Predictors of Progression in Systemic Sclerosis Patients With Interstitial Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2020English

Initial Predictors of Survival in Patients With Systemic Sclerosis (Scleroderma).

Keio Journal of Medicine
Medicine
1992English

Systemic Sclerosis (Scleroderma) and Malignancy

Japanese Journal of Clinical Immunology
2004English

Systemic Sclerosis (Scleroderma). Introduction.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1991English

Estimating Benefits From Immunesuppressive Treatment in Diffuse Cutaneous Systemic Sclerosis: Data From the Canadian Scleroderma Research Group

Open Journal of Rheumatology and Autoimmune Diseases
2014English

Organizing Diffuse Alveolar Damage Associated With Progressive Systemic Sclerosis

Mayo Clinic Proceedings
Medicine
1997English

Diffuse Systemic Sclerosis

2004English

Biomarkers of Disease Activity and Organ Damage in Systemic Lupus Erythematosus

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy